Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,580
Closed -$1.03M 189
2023
Q4
$1.03M Buy
+3,580
New +$975K 0.09% 118
2023
Q1
Sell
-9,828
Closed -$2.58M 162
2022
Q4
$2.58M Sell
9,828
-64
-0.6% -$17.2K 0.27% 72
2022
Q3
$2.23M Hold
9,892
0.24% 70
2022
Q2
$2.41M Buy
9,892
+9,792
+9,792% +$2.4M 0.23% 73
2022
Q1
$24K Buy
+100
New +$23K ﹤0.01% 175
2021
Q3
Sell
-8,177
Closed -$1.99M 187
2021
Q2
$1.99M Buy
8,177
+3,827
+88% +$941K 0.16% 96
2021
Q1
$1.08M Sell
4,350
-4,273
-50% -$1.02M 0.09% 122
2020
Q4
$1.98M Buy
8,623
+24
+0.3% +$5.53K 0.18% 88
2020
Q3
$2.19M Buy
8,599
+2,800
+48% +$694K 0.23% 78
2020
Q2
$1.37M Sell
5,799
-3,075
-35% -$702K 0.14% 94
2020
Q1
$1.8M Buy
8,874
+3,350
+61% +$732K 0.22% 84
2019
Q4
$1.33M Hold
5,524
0.12% 101
2019
Q3
$1.07M Sell
5,524
-12
-0.2% -$2.3K 0.1% 98
2019
Q2
$1.02M Buy
5,536
+1,006
+22% +$180K 0.1% 104
2019
Q1
$860K Buy
4,530
+831
+22% +$159K 0.09% 110
2018
Q4
$720K Sell
3,699
-2,300
-38% -$449K 0.08% 111
2018
Q3
$1.24M Buy
5,999
+1,175
+24% +$232K 0.12% 100
2018
Q2
$891K Buy
+4,824
New +$853K 0.09% 109
2016
Q3
Sell
-1,847
Closed -$281K 61
2016
Q2
$281K Buy
+1,847
New +$287K 0.04% 52
2016
Q1
Sell
-1,980
Closed -$321K 59
2015
Q4
$321K Buy
+1,980
New +$311K 0.04% 57

Other funds holding AMGN

Cumberland Partners's AMGN Position: Q1 2024 in Review

Cumberland Partners sold out of Amgen (AMGN) in Q1 2024, closing a stake of 3,580 shares — an estimated $1.03M sold.

Cumberland Partners first reported a position in AMGN in Q4 2015 and held it in 20 quarters. The position peaked at $2.58M in Q4 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Cumberland Partners reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Cumberland Partners sold 3,580 Amgen shares in Q1 2024, an estimated $1.03M.
  • Cumberland Partners first reported a position in Amgen in Q4 2015 and held it in 20 quarters.
  • Cumberland Partners's Amgen position peaked at $2.58M in Q4 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cumberland Partners's 13F filing for Q1 2024, filed 9 May 2024.